 | |
| Legal status | |
|---|---|
| Legal status |
|
| Identifiers | |
| |
| CAS Number | |
| PubChem CID | |
| UNII | |
| ChEMBL | |
| Chemical and physical data | |
| Formula | C23H27ClO7 |
| Molar mass | 450.91 g·mol−1 |
| 3D model ( JSmol) | |
| |
| |
Rongliflozin is an SGLT2 inhibitor developed as a potential treatment for diabetes. [1] [2]
References
- ^ Zhang H, Liu J, Zhu X, Li X, Chen H, Wu M, et al. (May 2020). "A Phase I Study on the Pharmacokinetics and Pharmacodynamics of DJT1116PG, a Novel Selective Inhibitor of Sodium-glucose Cotransporter Type 2, in Healthy Individuals at Steady State". Clinical Therapeutics. 42 (5): 892–905.e3. doi: 10.1016/j.clinthera.2020.03.007. PMID 32265061.
- ^ Zhang H, Zhu X, Li X, Chen H, Wu M, Li C, et al. (February 2020). "Pharmacokinetics and pharmacodynamics of rongliflozin, a novel selective inhibitor of sodium-glucose co-transporter-2, in people with type 2 diabetes mellitus". Diabetes, Obesity & Metabolism. 22 (2): 191–202. doi: 10.1111/dom.13887. PMID 31588657.
|
| |
| Legal status | |
|---|---|
| Legal status |
|
| Identifiers | |
| |
| CAS Number | |
| PubChem CID | |
| UNII | |
| ChEMBL | |
| Chemical and physical data | |
| Formula | C23H27ClO7 |
| Molar mass | 450.91 g·mol−1 |
| 3D model ( JSmol) | |
| |
| |
Rongliflozin is an SGLT2 inhibitor developed as a potential treatment for diabetes. [1] [2]
References
- ^ Zhang H, Liu J, Zhu X, Li X, Chen H, Wu M, et al. (May 2020). "A Phase I Study on the Pharmacokinetics and Pharmacodynamics of DJT1116PG, a Novel Selective Inhibitor of Sodium-glucose Cotransporter Type 2, in Healthy Individuals at Steady State". Clinical Therapeutics. 42 (5): 892–905.e3. doi: 10.1016/j.clinthera.2020.03.007. PMID 32265061.
- ^ Zhang H, Zhu X, Li X, Chen H, Wu M, Li C, et al. (February 2020). "Pharmacokinetics and pharmacodynamics of rongliflozin, a novel selective inhibitor of sodium-glucose co-transporter-2, in people with type 2 diabetes mellitus". Diabetes, Obesity & Metabolism. 22 (2): 191–202. doi: 10.1111/dom.13887. PMID 31588657.